Global Financial Private Client’s Thermo Fisher Scientific TMO Stock Holding History

Global Financial Private Client’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-270	Closed	-$134K	–	1465
2025 Q1	$134K	Buy	270 +59	+28%	+$32K	0.05%	239
2024 Q4	$110K	Sell	211 -14	-6%	-$7.7K	0.04%	256
2024 Q3	$139K	Buy	225 +67	+42%	+$39.7K	0.05%	223
2024 Q2	$87.4K	Hold	158	–	–	0.04%	251
2024 Q1	$91.2K	Hold	158	–	–	0.04%	248
2023 Q4	$83.9K	Sell	158 -15	-9%	-$7.26K	0.04%	246
2023 Q3	$85.8K	Hold	173	–	–	0.04%	228
2023 Q2	$89.8K	Hold	173	–	–	0.04%	233
2023 Q1	$98.6K	Hold	173	–	–	0.05%	210
2022 Q4	$95.3K	Buy	173 +6	+4%	+$3.18K	0.05%	201
2022 Q3	$87.3K	Hold	167	–	–	0.05%	207
2022 Q2	$91.6K	Buy	167 +28	+20%	+$15.4K	0.05%	195
2022 Q1	$82.3K	Buy	139 +15	+12%	+$8.62K	0.04%	219
2021 Q4	$82.7K	Hold	124	–	–	0.04%	226
2021 Q3	$71K	Hold	124	–	–	0.04%	218
2021 Q2	$63.2K	Hold	124	–	–	0.04%	221
2021 Q1	$56.6K	Hold	124	–	–	0.04%	196
2020 Q4	$57.8K	Buy	124 +6	+5%	+$2.81K	0.05%	184
2020 Q3	$51.7K	Hold	118	–	–	0.04%	185
2020 Q2	$42.5K	Hold	118	–	–	0.04%	230
2020 Q1	$32.5K	Sell	118 -58	-33%	-$18.3K	0.03%	255
2019 Q4	$57.2K	Buy	+176	New	+$53.4K	0.05%	222

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Global Financial Private Client's TMO Position: Q2 2025 in Review

Global Financial Private Client sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 270 shares — an estimated $134K sold.

Global Financial Private Client first reported a position in TMO in Q4 2019 and held it in 22 quarters. The position peaked at $139K in Q3 2024. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Global Financial Private Client reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 270 Thermo Fisher Scientific shares in Q2 2025, an estimated $134K.
Global Financial Private Client first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 22 quarters.
Global Financial Private Client's Thermo Fisher Scientific position peaked at $139K in Q3 2024.
2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.